Skip to content

Study on the effectiveness and safety of exercise rehabilitation programs in patients with chronic thromboembolic pulmonary hypertension

Study on the effectiveness and safety of exercise rehabilitation programs in patients with chronic thromboembolic pulmonary hypertension

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085732
Enrollment
Unknown
Registered
2024-06-17
Start date
2024-06-20
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic thromboembolic pulmonary hypertension

Interventions

Intervention group:On the basis of routine treatment, add in hospital rehabilitation combined with home exercise rehabilitation treatment
control group:conventional therapy

Sponsors

Beijing Anzhen Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1) Age = 18 years old; 2) Diagnosed CTEPH; 3) Stable after PEA, BPA, and targeted therapy; 4) WHO functional classification II/III; 5) Sign written informed consent

Exclusion criteria

Exclusion criteria: 1) Other types of pH; 2) Fainting or malignant arrhythmia within 2 weeks; 3) Unable to undergo exercise rehabilitation training due to skeletal or muscle abnormalities; 4) Accompanied by persistent arrhythmia, severe chronic or acute liver, kidney or central nervous system diseases; 5) Expected inability to complete follow-up within 1 year after enrollment; 6) Refusal or inability to sign informed consent, or the researcher's judgment of other situations that may affect the progress of clinical research and the determination of research results.

Design outcomes

Primary

MeasureTime frame
6-minute walking distance;

Secondary

MeasureTime frame
WHO functional classification;EmPHasis-10 pulmonary hypertension health quality of life score;Pulmonary hemodynamic evaluation indicators (mPAP, PVR, CO, CI, RAP, SvO2);Readmission due to worsening condition;All-cause death;Serious adverse events related to exercise;

Countries

China

Contacts

Public ContactWan Jun

Beijing Anzhen Hospital Affiliated to Capital Medical University

blueswan2013@yahoo.com+86 158 1058 2091

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026